Close Menu

NEW YORK (GenomeWeb) – Interpace Diagnostics announced today that it has signed an agreement making clinical services provider Best Med Opinion the exclusive distributor of Interpace’s cancer molecular diagnostics in Israel.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.